What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His scientific interests lie mostly in Internal medicine, Surgery, Cancer, Oncology and Gastroenterology.
His research related to Transplantation, Leukemia, Fludarabine, Chemotherapy and Survival rate might be considered part of Internal medicine.
His Surgery study combines topics from a wide range of disciplines, such as Neoadjuvant therapy, Carcinoma, Renal cell carcinoma and Odds ratio.
His work deals with themes such as Proportional hazards model, Nomogram, Soft tissue sarcoma and Pathology, which intersect with Cancer.
Many of his research projects under Oncology are closely connected to Retroperitoneal liposarcoma and Atypical Lipomatous Tumor with Retroperitoneal liposarcoma and Atypical Lipomatous Tumor, tying the diverse disciplines of science together.
His research in Gastroenterology tackles topics such as Immunology which are related to areas like Disease.
His most cited work include:
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation (572 citations)
- Body surface area and body weight predict total liver volume in Western adults (413 citations)
- Phase I Trial of the Proteasome Inhibitor Bortezomib in Patients With Advanced Solid Tumors With Observations in Androgen-Independent Prostate Cancer (387 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Internal medicine, Oncology, Surgery, Cancer and Gastroenterology.
His research in Prostate cancer, Chronic lymphocytic leukemia, Chemotherapy, Fludarabine and Leukemia are components of Internal medicine.
His research integrates issues of Disease, Pathology and Immunology in his study of Oncology.
Many of his studies on Surgery involve topics that are commonly interrelated, such as Neoadjuvant therapy.
His Cancer research incorporates themes from Stage, Proportional hazards model, Retrospective cohort study and Hazard ratio.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Hematopoietic stem cell transplantation, Neutropenia, Toxicity, Phases of clinical research and Regimen.
He most often published in these fields:
- Internal medicine (61.02%)
- Oncology (32.93%)
- Surgery (24.21%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (61.02%)
- Oncology (32.93%)
- Cancer (22.76%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Oncology, Cancer, Gastroenterology and Cancer research.
All of his Internal medicine and Chemotherapy, Neutropenia, Prostate cancer, Disease and Retrospective cohort study investigations are sub-components of the entire Internal medicine study.
He focuses mostly in the field of Prostate cancer, narrowing it down to matters related to Urology and, in some cases, Statistics.
His Oncology research integrates issues from Venetoclax, Chronic lymphocytic leukemia, IGHV@, Myeloid leukemia and Hazard ratio.
His Cancer study also includes fields such as
- Diarrhea and related Colitis,
- Clinical trial together with Proportional hazards model.
His research in Gastroenterology intersects with topics in Surgical oncology and Gastric adenocarcinoma, Adenocarcinoma.
Between 2018 and 2021, his most popular works were:
- Ibrutinib and venetoclax for first-line treatment of CLL (160 citations)
- Early introduction of selective immunosuppressive therapy associated with favorable clinical outcomes in patients with immune checkpoint inhibitor–induced colitis (49 citations)
- Guidelines for Reporting of Statistics for Clinical Research in Urology. (34 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Chemotherapy
Internal medicine, Oncology, Cancer, Cancer research and Pancreatic cancer are his primary areas of study.
His research links Gastroenterology with Internal medicine.
His Oncology research focuses on Germline mutation and how it relates to Trisomy.
His Cancer research is multidisciplinary, incorporating elements of Standardized uptake value, Quartile and Diarrhea.
His research on Cancer research also deals with topics like
-
Genetic heterogeneity, Gene, Mutation, Pathogenesis and Missense mutation most often made with reference to IGHV@,
-
Ibrutinib which connect with Neutropenia, Fludarabine, Rituximab, Cyclophosphamide and Obinutuzumab.
His Pancreatic cancer research also works with subjects such as
-
Aerobic exercise and related Cancer treatment, Exercise program, Exercise prescription and Mean age,
-
Home based exercise, Quality of life, Preoperative treatment, Physical function and Adenocarcinoma most often made with reference to Prehabilitation.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
